180 related articles for article (PubMed ID: 29677352)
1. The Economic Burden of Visual Impairment and Comorbid Fatigue: A Cost-of-Illness Study (From a Societal Perspective).
Schakel W; van der Aa HPA; Bode C; Hulshof CTJ; van Rens GHMB; van Nispen RMA
Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):1916-1923. PubMed ID: 29677352
[TBL] [Abstract][Full Text] [Related]
2. Economic burden of blindness and visual impairment in Germany from a societal perspective: a cost-of-illness study.
Chuvarayan Y; Finger RP; Köberlein-Neu J
Eur J Health Econ; 2020 Feb; 21(1):115-127. PubMed ID: 31493181
[TBL] [Abstract][Full Text] [Related]
3. Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study.
Cruess AF; Zlateva G; Xu X; Soubrane G; Pauleikhoff D; Lotery A; Mones J; Buggage R; Schaefer C; Knight T; Goss TF
Pharmacoeconomics; 2008; 26(1):57-73. PubMed ID: 18088159
[TBL] [Abstract][Full Text] [Related]
4. The economic burden of major adult visual disorders in the United States.
Rein DB; Zhang P; Wirth KE; Lee PP; Hoerger TJ; McCall N; Klein R; Tielsch JM; Vijan S; Saaddine J
Arch Ophthalmol; 2006 Dec; 124(12):1754-60. PubMed ID: 17159036
[TBL] [Abstract][Full Text] [Related]
5. Measurement of indirect costs for people with vision impairment.
Chou SL; Misajon R; Gallo J; Keeffe JE
Clin Exp Ophthalmol; 2003 Aug; 31(4):336-40. PubMed ID: 12880460
[TBL] [Abstract][Full Text] [Related]
6. The increased cost of medical services for people diagnosed with primary open-angle glaucoma: a decision analytic approach.
Kymes SM; Plotzke MR; Li JZ; Nichol MB; Wu J; Fain J
Am J Ophthalmol; 2010 Jul; 150(1):74-81. PubMed ID: 20493465
[TBL] [Abstract][Full Text] [Related]
7. Costs of interventions for visual impairment.
Taylor HR; Pezzullo ML; Nesbitt SJ; Keeffe JE
Am J Ophthalmol; 2007 Apr; 143(4):561-5. PubMed ID: 17222383
[TBL] [Abstract][Full Text] [Related]
8. Extent of Exacerbation of Chronic Health Conditions by Visual Impairment in Terms of Health-Related Quality of Life.
Park SJ; Ahn S; Woo SJ; Park KH
JAMA Ophthalmol; 2015 Nov; 133(11):1267-75. PubMed ID: 26379209
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with vision-related quality of life among the adult population living in Nagorno Karabagh.
Harutyunyan T; Giloyan A; Petrosyan V
Public Health; 2017 Dec; 153():137-146. PubMed ID: 29049920
[TBL] [Abstract][Full Text] [Related]
10. Economic burden of multimorbidity among older adults: impact on healthcare and societal costs.
Picco L; Achilla E; Abdin E; Chong SA; Vaingankar JA; McCrone P; Chua HC; Heng D; Magadi H; Ng LL; Prince M; Subramaniam M
BMC Health Serv Res; 2016 May; 16():173. PubMed ID: 27160080
[TBL] [Abstract][Full Text] [Related]
11. Exploring the patient perspective of fatigue in adults with visual impairment: a qualitative study.
Schakel W; Bode C; van der Aa HPA; Hulshof CTJ; Bosmans JE; van Rens GHMB; van Nispen RMA
BMJ Open; 2017 Aug; 7(8):e015023. PubMed ID: 28775181
[TBL] [Abstract][Full Text] [Related]
12. E-nergEYEze, a vision-specific eHealth intervention based on cognitive behavioral therapy and self-management to reduce fatigue in adults with visual impairment: study protocol for a randomized controlled trial.
Veldman MHJ; van der Aa HPA; Bode C; Knoop H; Hulshof CTJ; Koopmanschap M; Stavleu E; van Rens GHMB; van Nispen RMA
Trials; 2021 Dec; 22(1):966. PubMed ID: 34963472
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of non-medical costs associated with visual impairment in four European countries: France, Italy, Germany and the UK.
Lafuma A; Brézin A; Lopatriello S; Hieke K; Hutchinson J; Mimaud V; Berdeaux G
Pharmacoeconomics; 2006; 24(2):193-205. PubMed ID: 16460138
[TBL] [Abstract][Full Text] [Related]
14. The cost of visual impairment: purposes, perspectives, and guidance.
Frick KD; Kymes SM; Lee PP; Matchar DB; Pezzullo ML; Rein DB; Taylor HR;
Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):1801-5. PubMed ID: 20071669
[No Abstract] [Full Text] [Related]
15. An estimation of the worldwide economic and health burden of visual impairment.
Gordois A; Cutler H; Pezzullo L; Gordon K; Cruess A; Winyard S; Hamilton W; Chua K
Glob Public Health; 2012; 7(5):465-81. PubMed ID: 22136197
[TBL] [Abstract][Full Text] [Related]
16. Self-reported fall and associated factors among adult people with visual impairment in Gondar, Ethiopia: a cross-sectional study.
Gashaw M; Janakiraman B; Minyihun A; Jember G; Sany K
BMC Public Health; 2020 Apr; 20(1):498. PubMed ID: 32295572
[TBL] [Abstract][Full Text] [Related]
17. Impact of severity and bilaterality of visual impairment on health-related quality of life.
Varma R; Wu J; Chong K; Azen SP; Hays RD;
Ophthalmology; 2006 Oct; 113(10):1846-53. PubMed ID: 16889831
[TBL] [Abstract][Full Text] [Related]
18. Economic evaluation of stepped-care versus usual care for depression and anxiety in older adults with vision impairment: randomized controlled trial.
van der Aa HPA; van Rens GHMB; Bosmans JE; Comijs HC; van Nispen RMA
BMC Psychiatry; 2017 Aug; 17(1):280. PubMed ID: 28764679
[TBL] [Abstract][Full Text] [Related]
19. The economic impact and cost of visual impairment in Australia.
Taylor HR; Pezzullo ML; Keeffe JE
Br J Ophthalmol; 2006 Mar; 90(3):272-5. PubMed ID: 16488942
[TBL] [Abstract][Full Text] [Related]
20. Drivers of cost and health-related quality of life in patients with systemic lupus erythematosus (SLE): a Swedish nationwide study based on patient reports.
Bexelius C; Wachtmeister K; Skare P; Jönsson L; Vollenhoven Rv
Lupus; 2013 Jul; 22(8):793-801. PubMed ID: 23761101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
